These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2280278)

  • 1. Human growth hormone and Creutzfeldt-Jakob disease.
    Zekauskas S; Boggs MB; Wilson DP
    J Okla State Med Assoc; 1990 Sep; 83(9):447-8. PubMed ID: 2280278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
    Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
    Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological aspects of Creutzfeldt-Jakob disease related to the extractive growth hormone].
    Deslys JP
    Pathol Biol (Paris); 1995 Feb; 43(2):97-103. PubMed ID: 7777386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States.
    Fradkin JE; Schonberger LB; Mills JL; Gunn WJ; Piper JM; Wysowski DK; Thomson R; Durako S; Brown P
    JAMA; 1991 Feb; 265(7):880-4. PubMed ID: 1992185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
    Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human growth hormone distribution discontinued.
    FDA Drug Bull; 1985 Aug; 15(2):17-8. PubMed ID: 3902547
    [No Abstract]   [Full Text] [Related]  

  • 7. Creutzfeldt-Jakob disease in patients who received a cadaveric dura mater graft--Spain, 1985-1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Jul; 42(28):560-3. PubMed ID: 8326950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation].
    Rikken B; Massa GG; Wit JM; van den Brande JL
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1163-5. PubMed ID: 8692348
    [No Abstract]   [Full Text] [Related]  

  • 9. Human pituitary growth hormone (hGH) and Creutzfeldt-Jakob disease: results of an epidemiological survey in France, 1986.
    Goujard J; Entat M; Maillard F; Mugnier E; Rappaport R; Job JC
    Int J Epidemiol; 1988 Jun; 17(2):423-7. PubMed ID: 3042652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977.
    Abrams JY; Schonberger LB; Belay ED; Maddox RA; Leschek EW; Mills JL; Wysowski DK; Fradkin JE
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1666-9. PubMed ID: 21816775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iatrogenic Creutzfeldt-Jakob disease.
    Rappaport EB
    Neurology; 1987 Sep; 37(9):1520-2. PubMed ID: 3306455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts.
    Brown P
    Pediatrics; 1988 Jan; 81(1):85-92. PubMed ID: 3275936
    [No Abstract]   [Full Text] [Related]  

  • 13. Creutzfeldt-Jakob disease acquired via a dural graft: failure of therapy with quinacrine and chlorpromazine.
    Martínez-Lage JF; Rábano A; Bermejo J; Martínez Pérez M; Guerrero MC; Contreras MA; Lunar A
    Surg Neurol; 2005 Dec; 64(6):542-5, discussion 545. PubMed ID: 16293480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients.
    Mills JL; Schonberger LB; Wysowski DK; Brown P; Durako SJ; Cox C; Kong F; Fradkin JE
    J Pediatr; 2004 Apr; 144(4):430-6. PubMed ID: 15069388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of Creutzfeldt-Jakob disease associated with the use of human pituitary growth hormone.
    Will RG
    Dev Biol Stand; 1991; 75():85-6. PubMed ID: 1794632
    [No Abstract]   [Full Text] [Related]  

  • 16. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
    Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
    Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts -- Japan, January 1979-May 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(45):1066-9. PubMed ID: 9385874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contaminated material caused Creutzfeld-Jakob disease (CJD) in some undersized children who were treated with growth hormone (GH).
    Stockdale T
    Nutr Health; 2000; 14(2):141-2. PubMed ID: 10904939
    [No Abstract]   [Full Text] [Related]  

  • 19. Thinking the unthinkable: Alzheimer's, Creutzfeldt-Jakob and Mad Cow disease: the age-related reemergence of virulent, foodborne, bovine tuberculosis or losing your mind for the sake of a shake or burger.
    Broxmeyer L
    Med Hypotheses; 2005; 64(4):699-705. PubMed ID: 15694685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creutzfeldt-Jakob disease: current U.S. policy to further reduce the possible risk of transmission by transfusion.
    Menache D; O'Malley JP
    Biologicals; 1996 Sep; 24(3):277-83. PubMed ID: 8978926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.